Mirikizumab regulates genes involved in ulcerative colitis disease activity and anti-TNF resistance: results from a phase 2 study : Clinical and Translational Gastroenterology

Secondary Logo

Journal Logo

ARTICLE: Inflammatory Bowel Disease

Mirikizumab regulates genes involved in ulcerative colitis disease activity and anti-TNF resistance: results from a phase 2 study

Steere, Boyd1; Schmitz, Jochen1; Powell, Nick2; Higgs, Richard1; Gottlieb, Klaus1; Liu, Yushi1; Jia, Bochao1; Tuttle, Jay L1; Sandborn, William J3; Sands, Bruce E4; D’Haens, Geert5; Reinisch, Walter6; Krishnan, Venkatesh1,*

Author Information
Clinical and Translational Gastroenterology ():10.14309/ctg.0000000000000578, March 07, 2023. | DOI: 10.14309/ctg.0000000000000578
  • Open
  • PAP

Abstract

© 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology